{"id":57910,"date":"2023-08-18T01:05:51","date_gmt":"2023-08-17T23:05:51","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/the-national-hemophilia-foundation-is-now-the-national-bleeding-disorders-foundation\/"},"modified":"2023-08-18T01:05:51","modified_gmt":"2023-08-17T23:05:51","slug":"the-national-hemophilia-foundation-is-now-the-national-bleeding-disorders-foundation","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/the-national-hemophilia-foundation-is-now-the-national-bleeding-disorders-foundation\/","title":{"rendered":"The National Hemophilia Foundation is Now the National Bleeding Disorders Foundation"},"content":{"rendered":"<div>\n<p>\n<b>New Name, New Look, Expanded Vision<\/b><\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20230817074132\/en\/1870147\/5\/NBDF_Horizontal_Tagline-RGB.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20230817074132\/en\/1870147\/21\/NBDF_Horizontal_Tagline-RGB.jpg\"><\/a><br \/><a href=\"https:\/\/mms.businesswire.com\/media\/20230817074132\/en\/1870147\/5\/NBDF_Horizontal_Tagline-RGB.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20230817074132\/en\/1870147\/22\/NBDF_Horizontal_Tagline-RGB.jpg\"><\/a><\/p>\n<p>NATIONAL HARBOR, Md.&#8211;(BUSINESS WIRE)&#8211;The National Hemophilia Foundation (NHF) has officially changed its name to the National Bleeding Disorders Foundation (NBDF). Foundation leaders announced the change alongside advocates and supporters at the 2023 Bleeding Disorders Conference in National Harbor, MD.<\/p>\n<p>\nThe Foundation was established 75 years ago to help people living with hemophilia, but over time has evolved to serve those facing other inheritable blood and bleeding disorders such as von Willebrand disease, rare factor deficiencies, platelet disorders, and more. Through a powerful combination of research, education, and advocacy, NBDF has improved the lives of people and families with many different blood and bleeding disorders.<\/p>\n<p>\nIn recent decades, the Foundation also expanded its focus to include health equity, working to identify and eliminate barriers to care for underserved populations across the U.S. This rebrand aims to address concerns around diversity, inclusion, and equity to ensure every person and family facing an inheritable blood or bleeding disorder has access to the advanced care and support they need \u2014 regardless of gender, age, ethnicity, location, or socioeconomic background \u2014 so they can achieve their highest level of health.<\/p>\n<p>\nIn addition to the new name, the National Bleeding Disorders Foundation unveiled a new visual identity and logo intended to represent a wide range of inheritable blood and bleeding disorders, as well as a new tagline: Innovate | Educate | Advocate.<\/p>\n<p>\n\u201cOur new name is one that\u2019s inclusive, trying to represent that entire blood and bleeding disorders community based on our past. We think that this really embraces what we\u2019re going to offer into the future by bringing everybody in and offering them something. No matter what disorder you have, you will find a home in the National Bleeding Disorders Foundation,\u201d said Dr. Len Valentino, CEO.<\/p>\n<p>\nAs NBDF, the organization\u2019s mission will remain the same. It will continue to support a network of over 50 chapters across the country and channel funds into inheritable blood and bleeding disorders research. It will also continue to educate and support families with these disorders \u2014 along with the clinicians who care for them \u2014 and work to protect and expand access to health care on the state and local level.<\/p>\n<p>\nIn the near future, NBDF will seek ways to harness its resources and networks to help people facing an even broader array of inheritable blood and bleeding disorders, based on the understanding that bleeding disorders <i>are<\/i> blood disorders. Many of these disorders do not yet have a national support and advocacy network, and NBDF will determine how best to fill that role. This new name aligns with that vision for the future. The Foundation\u2019s national and affiliate chapters will play an important role in introducing the rebrand to the community. The strong connections they foster and support they provide at the local level will be key to NBDF\u2019s success.<\/p>\n<p>\n\u201cNow is the time to better reflect all of those that we serve,\u201d said Dawn Rotellini, COO. \u201cFor decades, the Foundation has served the hemophilia community and other conditions, but even though our work supported people and families impacted by ultra-rare blood and bleeding disorders as well as those with von Willebrand disease and more, our name and look did not properly reflect that. I&#8217;m so excited to introduce the National Bleeding Disorders Foundation, an organization that can now truly say it\u2019s a home to so many.\u201d<\/p>\n<p>\nNBDF will continue to roll out the new name and identity in the coming months. NBDF leaders and staff wish to thank the community in advance for their patience during this transition to the new brand. To learn more, visit <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.hemophilia.org&amp;esheet=53541635&amp;newsitemid=20230817074132&amp;lan=en-US&amp;anchor=www.hemophilia.org&amp;index=1&amp;md5=d9a922936691acaec756d450d9ab0f9c\" rel=\"nofollow noopener\" shape=\"rect\">www.hemophilia.org<\/a>, or follow the Foundation on its updated social media handles:<\/p>\n<ul class=\"bwlistdisc\">\n<li>\nX, formerly known as Twitter: @NBDFoundation and @NBDFespanol<\/li>\n<li>\nLinkedIn: @NationalBleedingDisordersFoundation<\/li>\n<li>\nFacebook: @NationalBleedingDisordersFoundation<\/li>\n<li>\nTikTok: @natlbdfoundation<\/li>\n<li>\nInstagram: @natlbdfoundation<\/li>\n<\/ul>\n<p>\nGeneral questions about the rebrand can be directed to <a target=\"_blank\" href=\"ma&#105;&#108;&#116;&#x6f;&#x3a;&#x63;&#x6f;mm&#117;&#110;&#105;&#x63;&#x61;&#x74;&#x69;on&#115;&#64;&#104;&#x65;&#x6d;&#x6f;&#x70;hi&#108;&#105;&#97;&#x2e;&#x6f;&#x72;&#x67;\" rel=\"nofollow noopener\" shape=\"rect\">&#99;&#x6f;&#x6d;m&#117;&#x6e;&#x69;c&#97;&#x74;i&#111;&#x6e;&#x73;&#64;&#104;&#x65;m&#111;&#x70;&#x68;i&#108;&#x69;&#x61;&#46;&#x6f;&#x72;g<\/a>.<\/p>\n<p>\nFor 75 years, the National Bleeding Disorders Foundation (NBDF) has championed research, education, and advocacy for inheritable blood<i> <\/i>and bleeding disorders. NBDF is dedicated to finding better treatments, preventative measures, and cures for these disorders. Founded by patients in 1948, NBDF\u2019s impactful programs and initiatives are made possible through the support of a nationwide network of chapters, as well as individuals, partners, and a cooperative agreement with the Centers for Disease Control and Prevention (CDC). Learn more at hemophilia.org.<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\n<b>MEDIA:<\/b><br \/><b>Ilana Ostrin<\/b><br \/><a target=\"_blank\" href=\"&#x6d;&#x61;&#x69;&#x6c;&#116;&#111;:io&#x73;&#x74;&#x72;&#x69;&#110;&#64;hem&#x6f;&#x70;&#x68;&#x69;&#108;&#105;&#97;&#46;o&#x72;&#x67;\" rel=\"nofollow noopener\" shape=\"rect\"><b>&#105;&#x6f;&#115;&#x74;r&#x69;n&#64;&#x68;&#101;&#x6d;&#111;&#x70;h&#x69;l&#105;&#x61;&#46;&#x6f;r&#x67;<\/b><\/a><br \/><b>212 328 3769<\/b><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>New Name, New Look, Expanded Vision NATIONAL HARBOR, Md.&#8211;(BUSINESS WIRE)&#8211;The National Hemophilia Foundation (NHF) has officially changed its name to the National Bleeding Disorders Foundation (NBDF). Foundation leaders announced the change alongside advocates and supporters at the 2023 Bleeding Disorders Conference in National Harbor, MD. The Foundation was established 75 years ago to help people &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/the-national-hemophilia-foundation-is-now-the-national-bleeding-disorders-foundation\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-57910","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>The National Hemophilia Foundation is Now the National Bleeding Disorders Foundation - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/the-national-hemophilia-foundation-is-now-the-national-bleeding-disorders-foundation\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"The National Hemophilia Foundation is Now the National Bleeding Disorders Foundation - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"New Name, New Look, Expanded Vision NATIONAL HARBOR, Md.&#8211;(BUSINESS WIRE)&#8211;The National Hemophilia Foundation (NHF) has officially changed its name to the National Bleeding Disorders Foundation (NBDF). Foundation leaders announced the change alongside advocates and supporters at the 2023 Bleeding Disorders Conference in National Harbor, MD. The Foundation was established 75 years ago to help people ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/the-national-hemophilia-foundation-is-now-the-national-bleeding-disorders-foundation\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-08-17T23:05:51+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230817074132\/en\/1870147\/21\/NBDF_Horizontal_Tagline-RGB.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/the-national-hemophilia-foundation-is-now-the-national-bleeding-disorders-foundation\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/the-national-hemophilia-foundation-is-now-the-national-bleeding-disorders-foundation\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"The National Hemophilia Foundation is Now the National Bleeding Disorders Foundation\",\"datePublished\":\"2023-08-17T23:05:51+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/the-national-hemophilia-foundation-is-now-the-national-bleeding-disorders-foundation\\\/\"},\"wordCount\":744,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/the-national-hemophilia-foundation-is-now-the-national-bleeding-disorders-foundation\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230817074132\\\/en\\\/1870147\\\/21\\\/NBDF_Horizontal_Tagline-RGB.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/the-national-hemophilia-foundation-is-now-the-national-bleeding-disorders-foundation\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/the-national-hemophilia-foundation-is-now-the-national-bleeding-disorders-foundation\\\/\",\"name\":\"The National Hemophilia Foundation is Now the National Bleeding Disorders Foundation - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/the-national-hemophilia-foundation-is-now-the-national-bleeding-disorders-foundation\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/the-national-hemophilia-foundation-is-now-the-national-bleeding-disorders-foundation\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230817074132\\\/en\\\/1870147\\\/21\\\/NBDF_Horizontal_Tagline-RGB.jpg\",\"datePublished\":\"2023-08-17T23:05:51+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/the-national-hemophilia-foundation-is-now-the-national-bleeding-disorders-foundation\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/the-national-hemophilia-foundation-is-now-the-national-bleeding-disorders-foundation\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/the-national-hemophilia-foundation-is-now-the-national-bleeding-disorders-foundation\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230817074132\\\/en\\\/1870147\\\/21\\\/NBDF_Horizontal_Tagline-RGB.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230817074132\\\/en\\\/1870147\\\/21\\\/NBDF_Horizontal_Tagline-RGB.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/the-national-hemophilia-foundation-is-now-the-national-bleeding-disorders-foundation\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"The National Hemophilia Foundation is Now the National Bleeding Disorders Foundation\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"The National Hemophilia Foundation is Now the National Bleeding Disorders Foundation - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/the-national-hemophilia-foundation-is-now-the-national-bleeding-disorders-foundation\/","og_locale":"en_US","og_type":"article","og_title":"The National Hemophilia Foundation is Now the National Bleeding Disorders Foundation - Pharma Trend","og_description":"New Name, New Look, Expanded Vision NATIONAL HARBOR, Md.&#8211;(BUSINESS WIRE)&#8211;The National Hemophilia Foundation (NHF) has officially changed its name to the National Bleeding Disorders Foundation (NBDF). Foundation leaders announced the change alongside advocates and supporters at the 2023 Bleeding Disorders Conference in National Harbor, MD. The Foundation was established 75 years ago to help people ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/the-national-hemophilia-foundation-is-now-the-national-bleeding-disorders-foundation\/","og_site_name":"Pharma Trend","article_published_time":"2023-08-17T23:05:51+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230817074132\/en\/1870147\/21\/NBDF_Horizontal_Tagline-RGB.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/the-national-hemophilia-foundation-is-now-the-national-bleeding-disorders-foundation\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/the-national-hemophilia-foundation-is-now-the-national-bleeding-disorders-foundation\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"The National Hemophilia Foundation is Now the National Bleeding Disorders Foundation","datePublished":"2023-08-17T23:05:51+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/the-national-hemophilia-foundation-is-now-the-national-bleeding-disorders-foundation\/"},"wordCount":744,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/the-national-hemophilia-foundation-is-now-the-national-bleeding-disorders-foundation\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230817074132\/en\/1870147\/21\/NBDF_Horizontal_Tagline-RGB.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/the-national-hemophilia-foundation-is-now-the-national-bleeding-disorders-foundation\/","url":"https:\/\/pharma-trend.com\/en\/the-national-hemophilia-foundation-is-now-the-national-bleeding-disorders-foundation\/","name":"The National Hemophilia Foundation is Now the National Bleeding Disorders Foundation - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/the-national-hemophilia-foundation-is-now-the-national-bleeding-disorders-foundation\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/the-national-hemophilia-foundation-is-now-the-national-bleeding-disorders-foundation\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230817074132\/en\/1870147\/21\/NBDF_Horizontal_Tagline-RGB.jpg","datePublished":"2023-08-17T23:05:51+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/the-national-hemophilia-foundation-is-now-the-national-bleeding-disorders-foundation\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/the-national-hemophilia-foundation-is-now-the-national-bleeding-disorders-foundation\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/the-national-hemophilia-foundation-is-now-the-national-bleeding-disorders-foundation\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230817074132\/en\/1870147\/21\/NBDF_Horizontal_Tagline-RGB.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230817074132\/en\/1870147\/21\/NBDF_Horizontal_Tagline-RGB.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/the-national-hemophilia-foundation-is-now-the-national-bleeding-disorders-foundation\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"The National Hemophilia Foundation is Now the National Bleeding Disorders Foundation"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/57910","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=57910"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/57910\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=57910"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=57910"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=57910"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}